Search Results

There are 429742 results for: content related to: Antigen Presenting Cells as Drug Targets

  1. Dendritic Cells (DCs) in Immunity and Maintenance of Tolerance

    Antigen Presenting Cells: From Mechanisms to Drug Development

    Magali de Heusch, Guillaume Oldenhove, Muriel Moser, Pages: 503–522, 2006

    Published Online : 10 APR 2006, DOI: 10.1002/3527607021.ch14

  2. You have free access to this content
    Semi-Allogeneic Dendritic Cells Injected via the Intratumoural Injection Route Show Efficient Antitumour Effects in Cooperation with Host-Derived Professional Antigen-Presenting Cells

    Scandinavian Journal of Immunology

    Volume 72, Issue 6, December 2010, Pages: 476–490, H. Kondoh, S. Okano, K. Yoshida, Y. Yonemitsu, Y. Tomita, Y. Yoshikai, N. Wake and K. Sueishi

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1365-3083.2010.02461.x

  3. You have free access to this content
    Effective treatment of small murine hepatocellular carcinoma by dendritic cells

    Hepatology

    Volume 34, Issue 5, November 2001, Pages: 896–905, Wei-Chen Lee, Hui-Chuan Wang, Long-Bin Jeng, Yang-Jen Chiang, Chen-Rong Lia, Pei-Fang Huang, Miin-Fu Chen, Shiguang Qian and Lina Lu

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.29003

  4. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo

    Liver International

    Volume 34, Issue 3, March 2014, Pages: 447–461, Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs-Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt-Wolf and Maria A. Gonzalez-Carmona

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12284

  5. You have free access to this content
    Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: e213–e221, Anita Correll, Andrea Tuettenberg, Christian Becker and Helmut Jonuleit

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1600-0625.2009.01055.x

  6. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner

    NMR in Biomedicine

    Volume 25, Issue 4, April 2012, Pages: 570–579, Hyun Jung Joo, Hoe Suk Kim, Yoon Seok Choi, Hyeonjin Kim, Seung Ja Kim and Woo Kyung Moon

    Version of Record online : 18 OCT 2011, DOI: 10.1002/nbm.1774

  7. You have free access to this content
    Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

    Clinical & Experimental Immunology

    Volume 170, Issue 2, November 2012, Pages: 167–177, S. Hong, H. Li, J. Qian, J. Yang, Y. Lu and Q. Yi

    Version of Record online : 5 OCT 2012, DOI: 10.1111/j.1365-2249.2012.04642.x

  8. You have free access to this content
    Current Status and Future Perspectives of Dendritic Cell–Based Cancer Immunotherapy

    Scandinavian Journal of Immunology

    Volume 78, Issue 2, August 2013, Pages: 167–171, D. H. Yi and S. Appel

    Version of Record online : 21 JUL 2013, DOI: 10.1111/sji.12060

  9. You have free access to this content
    Monitoring of circulating angiogenic factors in dendritic cell–based cancer immunotherapy

    Cancer

    Volume 98, Issue 10, 15 November 2003, Pages: 2291–2301, Christine Brostjan, Anita Bayer, Anna Zommer, Alexander Gornikiewicz, Sebastian Roka, Thomas Benkö, Rubina Yaghubian, Raimund Jakesz, Günther Steger, Michael Gnant, Josef Friedl and Anton Stift

    Version of Record online : 29 SEP 2003, DOI: 10.1002/cncr.11776

  10. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 5, Issue 5, September/October 2013, Pages: 469–483, Gregory A. Dekaban, Amanda M. Hamilton, Corby A. Fink, Bryan Au, Sonali N. de Chickera, Emeline J. Ribot and Paula J. Foster

    Version of Record online : 30 APR 2013, DOI: 10.1002/wnan.1227

  11. Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy

    British Journal of Dermatology

    Volume 149, Issue 6, December 2003, Pages: 1128–1142, P. Thumann, M. Lüftl, I. Moc, M. Bagot, A. Bensussan, G. Schuler and L. Jenne

    Version of Record online : 11 DEC 2003, DOI: 10.1111/j.1365-2133.2003.05674.x

  12. Vaccinations With Dendritic Cells Primed With Apoptotic Tumor Cells Can Elicit Preventive Antitumor Immunity in a Poorly Immunogenic Animal Model of Squamous Cell Carcinoma

    The Laryngoscope

    Volume 117, Issue 9, September 2007, Pages: 1588–1593, Han-Sin Jeong, Hyunah Lee, Yejeung Ko and Young-Ik Son

    Version of Record online : 2 JAN 2009, DOI: 10.1097/MLG.0b013e31806dd073

  13. Dendritic Cell-Based Immunotherapy of Malignant Melanoma: Success and Limitations

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 5, Issue 3, March 2007, Pages: 190–196, Andrea Tuettenberg, Edgar Schmitt, Jürgen Knop and Helmut Jonuleit

    Version of Record online : 1 MAR 2007, DOI: 10.1111/j.1610-0387.2007.06179.x

  14. Breaking Tolerance to Tumors with Dendritic Cell-Based Immunotherapy

    Annals of the New York Academy of Sciences

    Volume 1058, Issue 1, November 2005, Pages: 96–104, INES MENDE and EDGAR G. ENGLEMAN

    Version of Record online : 22 JAN 2006, DOI: 10.1196/annals.1359.018

  15. You have free access to this content
    Combination of CTL-associated Antigen-4 Blockade and Depletion of CD25+ Regulatory T Cells Enhance Tumour Immunity of Dendritic Cell-based Vaccine in a Mouse Model of Colon Cancer

    Scandinavian Journal of Immunology

    Volume 71, Issue 2, February 2010, Pages: 70–82, Asim Saha and S. K. Chatterjee

    Version of Record online : 30 NOV 2009, DOI: 10.1111/j.1365-3083.2009.02355.x

  16. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?

    Reviews in Medical Virology

    Volume 12, Issue 5, September/October 2002, Pages: 297–319, Susanne Beckebaum, Vito R. Cicinnati and Guido Gerken

    Version of Record online : 29 AUG 2002, DOI: 10.1002/rmv.359

  17. You have free access to this content
    Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice

    International Journal of Cancer

    Volume 124, Issue 4, 15 February 2009, Pages: 877–888, Asim Saha, Malaya Bhattacharya-Chatterjee, Kenneth A. Foon, Esteban Celis and Sunil K. Chatterjee

    Version of Record online : 19 SEP 2008, DOI: 10.1002/ijc.24009

  18. You have free access to this content
    The immunotherapeutic potential of dendritic cells in type 1 diabetes

    Clinical & Experimental Immunology

    Volume 161, Issue 2, August 2010, Pages: 197–207, G. Mukherjee and T. P. DiLorenzo

    Version of Record online : 10 MAY 2010, DOI: 10.1111/j.1365-2249.2010.04157.x

  19. You have free access to this content
    Guiding the “misguided” – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours

    European Journal of Immunology

    Volume 41, Issue 1, January 2011, Pages: 18–25, Fang-Ping Huang, Yu-Xiao Chen and Christina KW To

    Version of Record online : 9 DEC 2010, DOI: 10.1002/eji.201040543

  20. You have free access to this content
    Report from the International Union Against Cancer (UICC) Tumor Biology Committee

    Cancer

    Volume 86, Issue 12, 15 December 1999, Pages: 2674–2683, Michael L. Salgaller, Martin Thurnher, Georg Bartsch, Alton L. Boynton and Gerald P. Murphy

    Version of Record online : 20 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19991215)86:12<2674::AID-CNCR12>3.0.CO;2-Z